BioCardia Inc (BCDA)
2.135
+0.14
(+7.29%)
USD |
NASDAQ |
Nov 21, 16:00
2.18
+0.04
(+2.11%)
Pre-Market: 08:21
BioCardia Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2020 | 89.47% |
| December 31, 2019 | 82.79% |
| September 30, 2019 | 87.63% |
| June 30, 2019 | -122.1% |
| March 31, 2019 | 50.93% |
| December 31, 2018 | -12.62% |
| September 30, 2018 | -29.76% |
| June 30, 2018 | 43.51% |
| March 31, 2018 | 21.11% |
| December 31, 2017 | -65.00% |
| September 30, 2017 | -13.08% |
| June 30, 2017 | -81.25% |
| March 31, 2017 | -27.74% |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
| Date | Value |
|---|---|
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | 80.67% |
| September 30, 2009 | 80.73% |
| June 30, 2009 | 80.27% |
| March 31, 2009 | 81.02% |
| December 31, 2008 | 82.74% |
| September 30, 2008 | 83.94% |
| June 30, 2008 | |
| March 31, 2008 | |
| December 31, 2007 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
82.79%
Minimum
Dec 2019
89.47%
Maximum
Mar 2020
86.13%
Average
86.13%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 82.85% |
| The Cooper Companies Inc | 66.11% |
| Theriva Biologics Inc | -- |
| Zevra Therapeutics Inc | 37.67% |
| Instil Bio Inc | -- |